# EDGAR Filing Document

**Accession Number:** 0001433234
**File Stem:** 0001127602-23-007404
**Filing Date:** 2023-2
**Character Count:** 9045
**Document Hash:** faf87360ac651d71e0acb6cfa33f8fa6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-007404.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001127602-23-007404

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230224

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Fay Edmund
- **CENTRAL INDEX KEY:** 0001433234

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10315
- **FILM NUMBER:** 23680277

**MAIL ADDRESS:**
- **STREET 1:** 3660 GRANDVIEW PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35243
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Encompass Health Corp
- **CENTRAL INDEX KEY:** 0000785161
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOSPITALS [8060]
- **IRS NUMBER:** 630860407
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242
- **BUSINESS PHONE:** 205-967-7116

**MAIL ADDRESS:**
- **STREET 1:** 9001 LIBERTY PARKWAY
- **CITY:** BIRMINGHAM
- **STATE:** AL
- **ZIP:** 35242

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH CORP
- **DATE OF NAME CHANGE:** 19950113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHSOUTH REHABILITATION CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```

POWER OF ATTORNEY

	Know all men by these presents that the undersigned
hereby constitutes and appoints Patrick Darby and
Stephen Leasure, and each of them individually, the
undersigned's true and lawful attorney-in-fact to:

       (1) 	execute for and on behalf of the
undersigned, in the capacity as an officer and/or
director of Encompass Health Corporation, a Delaware
corporation (the "Company"), Forms 3, 4 and 5, Schedule
13D and Schedule 13G and amendments thereto in accordance
with Sections 13(d) and 16(a) of the Securities Exchange
Act of 1934 and the rules thereunder, and any other
forms or reports the undersigned may be required to
file in connection with the undersigned's ownership,
acquisition, or disposition of securities of the Company;

       (2)	do and perform any and all acts for
and on behalf of the undersigned which may be necessary
or desirable to complete the execution of any such
Form 3, 4 or 5, Schedule 13D, Schedule 13G, or other
form or report, and timely file such form, schedule
or report with the United States Securities and
Exchange Commission and any other authority; and

	(3)	take any other action of any type
whatsoever in connection with the foregoing which,
in the opinion of each such attorney-in-fact, may be
of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that
the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in his
or her discretion.

	The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of a
ny of the rights and powers herein granted, as fully
to all intents and purposes as the undersigned might
or could do if personally present, with full power of
substitution or revocation, and hereby ratifies and
confirms all that such attorney-in-fact, or his or
her substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of Attorney
and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorney-in-fact, in serving
in such capacity at the request of the undersigned, is not
assuming any of the undersigned's responsibilities to comply
with Sections 13(d) and 16 of the Securities Exchange
Act of 1934.

	This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required to
file Forms 3, 4, and 5, Schedule 13D, Schedule 13G, or
other form or report with respect to the undersigned's
holdings of and transactions in securities issued by
the Company, unless revoked by the undersigned in a s
igned writing delivered to each foregoing attorney-in fact.

	IN WITNESS WHEREOF, the undersigned has caused
this Power of Attorney to be executed effectively as of
this 31st day of January 2023.

           /S/ EDMUND M. FAY
Edmund M. Fay

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Fay Edmund<br><sub>(Last) (First) (Middle)</sub><br>527 VALLEY ROAD<br><sub>(Street)</sub><br>BIRMINGHAM, AL 35206<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Sr. Vice Pres. and Treasurer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Encompass Health Corp [ EHC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Encompass Health Common Stock | 2023-02-24 |  | F |  | 299<sup>(1)</sup> | D | $60.22 | 98552 | D |  |
| Encompass Health Common Stock | 2023-02-27 |  | F |  | 383<sup>(1)</sup> | D | $60.22 | 98169 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

**Signature:** Patrick Darby, attorney-in-fact for Edmund Fay  
**Date:** 2023-02-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**